Medline Inc. Amortization of Debt Issuance Costs
Medline Inc. (MDLN) reported Amortization of Debt Issuance Costs of $24.00 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-05
- Medline Inc. amortization of debt issuance costs for the quarter ending 2026-06-27 was $13.00M, a 13.33% decline year-over-year.
- Medline Inc. amortization of debt issuance costs for the quarter ending 2026-03-28 was $11.00M, a 26.67% decline year-over-year.
- Medline Inc. amortization of debt issuance costs for the quarter ending 2025-06-28 was $15.00M.
- Medline Inc. amortization of debt issuance costs for the quarter ending 2025-03-29 was $15.00M.
- Medline Inc. amortization of debt issuance costs for fiscal 2025 was $59.00M, a 3.51% increase from fiscal 2024.
- Medline Inc. amortization of debt issuance costs for fiscal 2024 was $57.00M, a 28.75% decline from fiscal 2023.
- Medline Inc. amortization of debt issuance costs for fiscal 2023 was $80.00M.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2026-06-27 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $24.00M 10-Q · filed 2026-08-05 | |
| 2026-03-28 | $11.00M 10-Q · filed 2026-05-06 | ||
| 2025-12-31 | $59.00M 10-K · filed 2026-02-25 | ||
| 2025-06-28 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $30.00M 10-Q · filed 2026-08-05 | |
| 2025-03-29 | $15.00M 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | $57.00M 10-K · filed 2026-02-25 | ||
| 2023-12-31 | $80.00M 10-K · filed 2026-02-25 |